Advanced in COVID-19

Christian P. Putensen

Bonn, NW, DE 
Advanced in COVID-19
Bonn, NW, DE 
OverviewLocationsClinical Research

Overview

Christian Putensen practices in Bonn, Germany. Mr. Putensen is rated as an Advanced expert by MediFind in the treatment of COVID-19. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Sepsis, COVID-19, and Delirium.

His clinical research consists of co-authoring 183 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles and participated in 1 clinical trial in the study of COVID-19.

Gender
Male

Locations

Bonn, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS - a Randomised, Placebo-controlled, Double-blind Trial
Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS - a Randomised, Placebo-controlled, Double-blind Trial
Enrollment Status: Completed
Publish Date: May 14, 2025
Intervention Type: Drug
Study Phase: Phase 2
Randomised Controlled Multicentre Study of Albumin Replacement Therapy in Septic Shock
Randomised Controlled Multicentre Study of Albumin Replacement Therapy in Septic Shock
Enrollment Status: Terminated
Publish Date: October 28, 2024
Intervention Type: Drug
Study Drugs: Albutein, Plasbumin
Study Phase: Phase 3
A Randomized, Controlled, Multicenter, Parallel-Group Phase IIa Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of Severe COVID-19
A Randomized, Controlled, Multicenter, Parallel-Group Phase IIa Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of Severe COVID-19
Enrollment Status: Terminated
Publish Date: August 29, 2024
Intervention Type: Biological
Study Drug: Allogeneic Mesenchymal Stem Cells (MSC)
Study Phase: Phase 2
Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing
Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing
Enrollment Status: Completed
Publish Date: November 16, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 3 Less Clinical Trials

183 Total Publications

S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025
S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025
Journal: Medizinische Klinik, Intensivmedizin und Notfallmedizin
Published: July 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Putensen's expertise for a condition
ConditionClose
View All 17 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile